The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells.EBI
Istituto Italiano Di Tecnologia
Progress in the development ofß-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.EBI
Istituto Italiano Di Tecnologia
Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.EBI
Istituto Italiano Di Tecnologia
Synthesis, biological evaluation, and 3D QSAR study of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters as N-acylethanolamine acid amidase (NAAA) inhibitors.EBI
Istituto Italiano Di Tecnologia
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors.EBI
Istituto Italiano Di Tecnologia
Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.EBI
Istituto Italiano Di Tecnologia
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands.EBI
Istituto Italiano Di Tecnologia
Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease.EBI
Istituto Italiano Di Tecnologia
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.EBI
Istituto Italiano Di Tecnologia
Computer-aided identification, synthesis, and biological evaluation of DNA polymerase η inhibitors for the treatment of cancer.EBI
Istituto Italiano Di Tecnologia
Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors.EBI
Istituto Italiano Di Tecnologia
Synthetic Lethality through the Lens of Medicinal Chemistry.EBI
Istituto Italiano Di Tecnologia
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β.EBI
Istituto Italiano Di Tecnologia
Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times.EBI
Istituto Italiano Di Tecnologia
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.EBI
Istituto Italiano Di Tecnologia
Design, Synthesis, Dynamic Docking, Biochemical Characterization, and EBI
Istituto Italiano Di Tecnologia
Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity.EBI
Istituto Italiano Di Tecnologia
SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOFBDB
Gilead Sciences